These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 26605506)
1. Nutritional and Immunological Correlates of Memory and Neurocognitive Development Among HIV-Infected Children Living in Kayunga, Uganda. Ruiseñor-Escudero H; Familiar-Lopez I; Sikorskii A; Jambulingam N; Nakasujja N; Opoka R; Bass J; Boivin M J Acquir Immune Defic Syndr; 2016 Apr; 71(5):522-9. PubMed ID: 26605506 [TBL] [Abstract][Full Text] [Related]
2. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children. Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220 [TBL] [Abstract][Full Text] [Related]
3. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy. Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666 [TBL] [Abstract][Full Text] [Related]
4. Neruodevelopmental Outcomes in Preschool Children Living With HIV-1 Subtypes A and D in Uganda. Ruiseñor-Escudero H; Sikorskii A; Familiar-Lopez I; Persaud D; Ziemniak C; Nakasujja N; Opoka R; Boivin M Pediatr Infect Dis J; 2018 Dec; 37(12):e298-e303. PubMed ID: 29746376 [TBL] [Abstract][Full Text] [Related]
5. [T-cell subsets variation during clinical and immunological progression in vertically HIV-infected children]. Resino García S; Bellón Cano JM; Navarro Caspistegui J; Gurbindo Gutiérrez D; León Leal JA; Muñoz-Fernández MA Medicina (B Aires); 2001; 61(5 Pt 1):557-65. PubMed ID: 11721322 [TBL] [Abstract][Full Text] [Related]
6. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy. d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625 [TBL] [Abstract][Full Text] [Related]
7. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART. Resino S; Navarro J; Bellón JM; Gurbindo D; León JA; Muñoz-Fernández MA Clin Exp Immunol; 2001 Aug; 125(2):266-73. PubMed ID: 11529919 [TBL] [Abstract][Full Text] [Related]
8. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement. Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143 [TBL] [Abstract][Full Text] [Related]
9. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945 [TBL] [Abstract][Full Text] [Related]
10. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection. Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282 [TBL] [Abstract][Full Text] [Related]
11. CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy. Resino S; Seoane E; Gutiérrez MD; León JA; Muñoz-Fernández MA J Acquir Immune Defic Syndr; 2006 Jul; 42(3):269-76. PubMed ID: 16810122 [TBL] [Abstract][Full Text] [Related]
12. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression. Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319 [TBL] [Abstract][Full Text] [Related]
13. Immunological changes after highly active antiretroviral therapy with lopinavir-ritonavir in heavily pretreated HIV-infected children. Resino S; Galán I; Pérez A; Ramos JT; Bellón JM; Fontelos PM; de José MI; Gutiérrez MD; Cabrero E; Muñoz-Fernández MA AIDS Res Hum Retroviruses; 2005 May; 21(5):398-406. PubMed ID: 15929702 [TBL] [Abstract][Full Text] [Related]
14. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study. Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797 [TBL] [Abstract][Full Text] [Related]
15. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778 [TBL] [Abstract][Full Text] [Related]
16. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals. Kolber MA AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457 [TBL] [Abstract][Full Text] [Related]
17. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235 [TBL] [Abstract][Full Text] [Related]
18. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396 [TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV. Brahmbhatt H; Boivin M; Ssempijja V; Kigozi G; Kagaayi J; Serwadda D; Gray RH J Acquir Immune Defic Syndr; 2014 Nov; 67(3):316-22. PubMed ID: 25314252 [TBL] [Abstract][Full Text] [Related]